News

26 Mar 2021

QD view – there’s more to emerging markets than China

We have just published a note on Aberdeen Emerging Markets Investment Company, following a meeting with its managers, and our guest on this week’s news show was Ross Teverson, manager of Jupiter Emerging & Frontier Income. This week’s QD view picks up on some of the themes that came out of our discussions. The first […]

25 Mar 2021
ATR

Schroder Asia Total Return posts very healthy returns

Schroder Asia Total Return posts very healthy returns – Schroder Asian Total Return has published results for 2020 and they are good. A net asset value total return of 33.7% was significantly ahead of the benchmark, which returned 18.7%. The company also beat its peer group, which produced an average total return of 30.9%. Returns to […]

25 Mar 2021

International Public Partnerships sees modest hit from COVID

International Public Partnerships sees modest hit from COVID – International Public Partnerships says that it had a successful year in 2020, particularly against the wider backdrop of the global Covid-19 pandemic. The company met its dividend target of 7.36p per share for the year (2.5% more than for 2019) and has set out an ambition of […]

25 Mar 2021

NextEnergy Solar hits subsidy-free target

NextEnergy Solar hits subsidy-free target – NextEnergy Solar Fund has reached its subsidy-free development target of about 150MWp, through two newly approved subsidy-free development assets. Both assets are currently being prepared for construction and are expected to be energised in early 2022. The assets have an approximate investment value of £45m and comprise: Whitecross, a 124-acre […]

25 Mar 2021

Apax backs Rodenstock

Apax backs Rodenstock – the Apax X Fund, in which Apax Global Alpha has an investment (as a limited partner – in total it committed to invest about $450m in the fund), announced that it has entered into a definitive agreement to acquire a majority stake in Rodenstock Group, a leading manufacturer of premium ophthalmic lenses. […]

25 Mar 2021

QuotedData’s morning briefing 25 March 2021

In QuotedData’s morning briefing 25 March 2021: Tufton Oceanic Assets (SHIP) raised gross proceeds of US$14.7m by issuing 15m shares at 98 cents each. [It said that it was after $25m, so perhaps this was a little disappointing. That’s a surprise to us as shipping rates have been soaring.] The Renewables Infrastructure Group (TRIG) raised about […]

23 Mar 2021

Shake up at JPMorgan Multi Asset

Shake up at JPMorgan Multi Asset – JPMorgan Multi Asset Trust just passed its third birthday. It would be fair to say that the trust is sub-scale – with a market cap of £80m – and not particularly in demand – it currently trades on a discount of 11.8%. The board and the managers, believe […]

23 Mar 2021

BB Biotech top pick Ionis hit by safety setback

BB Biotech top pick Ionis hit by safety setback – BB Biotech’s top holding, US antisense therapeutics pioneer Ionis Pharmaceuticals, has suffered a material setback, after the independent committee monitoring trials of one of its lead development products – tominersen, which is partnered with the pharma giant Roche – recommended discontinuation of dosing in Phase III […]

23 Mar 2021

Temple Bar looks to brighter future

Temple Bar looks to brighter future – Temple Bar Investment Trust has published results for the year ended 31 December 2020. The first nine months were a difficult period for the trust – seeing it lose its manager and underperform significantly. Alastair Mundy’s retirement due to ill health prompted a review of management arrangements. RWC Partners […]

23 Mar 2021

Symphony optimistic despite COVID travel hit

Symphony optimistic despite COVID travel hit – Symphony International Holdings has announced results for the year ended 31 December 2020. The NAV attributable to the ordinary shares on 31 December 2020 was US$0.7384 per share. This represents a 24.70% decline over the NAV per share of US$0.9805 at 31 December 2019. The change is predominantly due to a […]